Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease
about
Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's diseaseCarbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairmentMR-less surface-based amyloid assessment based on 11C PiB PETBrain fuel metabolism, aging, and Alzheimer's diseaseEarly detection of Alzheimer's disease using MRI hippocampal textureBeta-amyloid deposition and the aging brainNew computer-aided diagnosis of dementia using positron emission tomography: brain regional sensitivity-mapping methodBasal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve.Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's diseaseAberrant Functional Connectivity Architecture in Participants with Chronic Insomnia Disorder Accompanying Cognitive Dysfunction: A Whole-Brain, Data-Driven AnalysisIncreased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.In vivo human amyloid imaging.Dissociation of Down syndrome and Alzheimer's disease effects with imaging.Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.Early detection of cerebral glucose uptake changes in the 5XFAD mouse.Mapping brain beta-amyloid.Comparison of 18F-FDG and PiB PET in cognitive impairment.Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trialsFluorodeoxyglucose positron emission tomography of mild cognitive impairment with clinical follow-up at 3 yearsMulti-Channel neurodegenerative pattern analysis and its application in Alzheimer's disease characterization.Cognition, glucose metabolism and amyloid burden in Alzheimer's disease.Reduced glucose uptake and Aβ in brain regions with hyperintensities in connected white matterMetal imaging in neurodegenerative diseases.Brain imaging in the study of Alzheimer's diseaseAn evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease.Protein tau: prime cause of synaptic and neuronal degeneration in Alzheimer's disease.In-vivo human brain molecular imaging with a brain-dedicated PET/MRI system.Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment.Early detection of Alzheimer's disease using PiB and FDG PETFDG and Amyloid PET in Cognitively Normal Individuals at Risk for Late-Onset Alzheimer's Disease.Biparietal variant of Alzheimer's disease: a rare presentation of a common disease.Amyloid imaging and memory change for prediction of cognitive impairment.Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controlsQuantitative analysis of PiB-PET with FreeSurfer ROIsComparing fludeoxyglucose F18-PET assessment of regional cerebral glucose metabolism and [11C]dihydrotetrabenazine-PET in evaluation of early dementia and mild cognitive impairmentMaternal age affects brain metabolism in adult children of mothers affected by Alzheimer's disease.Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly.Periodontal disease associates with higher brain amyloid load in normal elderly.Using biomarkers to improve detection of Alzheimer's disease.Optimal likelihood-ratio multiple testing with application to Alzheimer's disease and questionable dementia
P2860
Q22242926-E6666247-185F-4B3D-97CF-E0012C4F5AB0Q24235237-5FEA688A-3592-44C4-859A-84DDC310673CQ24618963-743396A5-63C8-445B-B160-E7D3578C15ACQ24625859-9BCC59CA-0DFA-44F0-BAA8-7479D478C7CBQ27907796-F4F005AF-B69F-4A60-8A65-EE651A5D81A9Q28264556-6653D5CA-C217-4118-AC2A-6867CEA79EB1Q28744562-67B4C3B6-C6CA-4A65-93F1-282E0E5BCD99Q30436083-BE6968AC-0B40-4B20-8D96-CE601781DC91Q33494855-7663E8EC-D65C-4420-8796-283EA19ED195Q33658717-AA039B5B-D551-41D8-AD69-5E25B581D9D5Q33778436-EAF9ECF4-A6DE-45F4-A70A-2A450043B62DQ33790277-120EBFC4-6D90-4F0C-914B-ED3F87204438Q33816076-E7F4989B-17E0-4A48-BA0B-8F7C21942938Q33834876-4FA38DA1-03C8-4114-8736-2051CCACD78AQ33846922-3D150153-C713-4075-9607-BBEB04772EB8Q33899600-6A791D15-006E-4EFA-A82E-8D04F961BE76Q33917282-2E592362-A7C0-466E-A2F4-4F5CB23DE683Q34014237-FB7906C5-0F45-45C3-8AF6-3AA1C19DF9C1Q34052882-19DFD721-0EF0-4CB6-B8BF-2A2C54602F39Q34053888-50DC2EDD-395E-4829-83CD-AC0C3A23B19EQ34061233-270A119F-AD1C-421D-AB09-486217BCD4F7Q34066828-458176D9-8F19-4D25-B4A8-003B46BB53C7Q34073566-E007198D-2F00-46E3-B850-923FBC5730E5Q34102331-70A7E20D-C974-4B65-957C-B3A08AE18F6FQ34126021-2251B01D-47D2-41B2-A9C8-E54EB135F432Q34283149-BA9F48C6-125F-470D-9A30-C693BBF07134Q34366557-0BADADBE-1595-4C6D-92A5-8F831CEC4E22Q34462406-C8974248-0429-4316-9AA2-DC2058F216E9Q34483878-08F7EFBF-627F-43F3-903B-603B10926FB4Q34730215-8B10429C-6FB9-4E24-9BA9-61F7C4F022CEQ34904398-19A67978-B34C-43E8-B07C-5D4B3B4502EEQ35029095-B32B17E1-2924-4460-A120-DF49FA4BA822Q35032948-AF36BC21-87B3-4919-8853-F1945D82C940Q35040068-290012EC-4E0E-4B83-8907-7F96CCC69115Q35120662-938ADED1-0FEA-4740-B10B-A086D114B1C9Q35161146-4880ABAB-2760-441A-A0D6-768E7B0025EAQ35231622-27D0E93E-09FE-438D-B4E6-62C793A30EA4Q35447921-7294123E-1C1F-4D17-B9DC-1528DF1701E9Q35533115-38A74A8F-2A20-4476-BAFB-9879977B26AEQ35551359-CDB43910-D5A9-423F-A86D-9C19DD0E5CB9
P2860
Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer's disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Regional analysis of FDG and P ...... rment, and Alzheimer's disease
@en
Regional analysis of FDG and P ...... ment, and Alzheimer's disease.
@nl
type
label
Regional analysis of FDG and P ...... rment, and Alzheimer's disease
@en
Regional analysis of FDG and P ...... ment, and Alzheimer's disease.
@nl
prefLabel
Regional analysis of FDG and P ...... rment, and Alzheimer's disease
@en
Regional analysis of FDG and P ...... ment, and Alzheimer's disease.
@nl
P2093
P2860
P1476
Regional analysis of FDG and P ...... rment, and Alzheimer's disease
@en
P2093
Byeong-Chae Kim
Elizabeth Pirraglia
Henry Rusinek
Juha O Rinne
Kjell Någren
Lisa Mosconi
Nina Kemppainen
Susan DeSanti
P2860
P2888
P304
P356
10.1007/S00259-008-0833-Y
P577
2008-06-20T00:00:00Z